Find a variety of Repligen Corp statistics including live RGEN stock quotes, market price charts, market cap, and everything you need to know to invest in RGEN.

Repligen Corp. 's earnings in 2021 is $59,926,000.. On average, 7 Wall Street analysts forecast RGEN's earnings for 2021 to be $100,655,403, with the lowest RGEN earnings forecast at $98,398,037, and the highest RGEN earnings forecast at $102,081,386.

Klättermusen AB- Specialist, Supply Chain på Repligen Corporation. Lund. Secure optimal range planning through analysis. Analyze and forecast performance, stock and identify risks. Take actions on missed opportunities and on missed opportunities and non-performing styles in season. Secure optimal range planning through analysis.

07:02 AM ET. Repligen agrees to buy Spectrum in a cash-and-stock deal valued at $359 mln MarketWatch. 06:59 AM ET. Repligen's stock halted for news pending Investing in stocks, such as Repligen, is an excellent way to grow wealth. For long-term investors, stocks are a good investment even during periods of the market volatility - a stock market downturn means that many stocks are on sale. Repligen market cap is $10.4 b, and annual revenue was $270.25 m in FY 2019. View Repligen stock / share price, financial statements, key ratios and more at Craft. RGEN: Get the latest Repligen stock price and detailed information including RGEN news, historical charts and realtime prices. 2 days ago Proposed A RTeSYN a cquisition adds gold standard single - use downstream bioprocessing s ystems Advances Repligen’s S ystems strategy in Filtration and Chromatography , c omplement ing TangenX ® F lat S heet cassettes and OPUS ® PP C Completes acquisition of Non-Metallic Solutions (NMS), complementing our recent acquisition of EMT and further strengthens our single-use flow paths, … Repligen’s stock exploded on Friday April 26, 2019 as it increased $11.65 (up 20%) to $68.89.

Jun 3, 2014 The acquisition strengthens Repligen's bioprocessing business by our volatile stock price; and other risks detailed in Repligen's annual

Security: Description: Exchange: SYMBOL: Common stock, $0.01 par value: EXCHANGE 2021-04-08 2021-01-01 View Repligen Corporation RGEN investment & stock information. Get the latest Repligen Corporation RGEN detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.

Repligen Cp stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions.

Based on analysts offering 12 month price targets for RGEN in the last 3 months. The average price target is $250.5 with a high estimate of $251 and a low Mar 26, 2021 Outlook.

Repligen last posted its earnings results on February 23rd, 2021. The biotechnology company reported $0.52 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.31 by $0.21. Repligen introduces novel affinity resin for the purification of the SARS CoV-2 Spike Protein for vaccine development and manufacturing. NGL COVID-19 Spike Protein Affinity Resin binds the SARS-CoV-2 Spike Protein receptor binding domain (RBD) to yield exceptional purity in a single chromatography step. RGEN stock forecast Our latest prediction for Repligen Corp.'s stock price was made on the March 12, 2021 when the stock price was at 194.70$.. In the short term (2weeks), RGEN's stock price should underperform the market by -1.43%.During that period the price should oscillate between -6.62% and +5.67%..
Heta arbeten karlskoga

And Louis Navellier sees a lot more upside for the company.

View which stocks have been most impacted by COVID-19. What guidance has Repligen issued on next quarter's earnings?
Nattevakt tips

November 10, 2020. 7:03 am ET. Repligen started at overweight with $241 stock price target at KeyBanc Capital. MarketWatch

ET by Tomi Kilgore Repligen agrees to buy Spectrum in a cash-and-stock deal valued at $359 mln Repligen (NASDAQ:RGEN) Earnings Information Repligen last announced its earnings data on February 23rd, 2021. The biotechnology company reported $0.52 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.31 by $0.21.

Anna wennergrund

Repligen’s stock exploded on Friday April 26, 2019 as it increased $11.65 (up 20%) to $68.89. This was primarily caused by the pre-announcement that the Company expected organic sales growth of 35-37% in the quarter which compares to consistent, past guidance from the Company that it aims to achieve 12% to 15% organic sales growth on a long term basis.

Price target in 14 days: 218.773 USD. The best long-term & short-term Repligen share price prognosis for 2021 REPLIGEN Stock Forecast, RGN stock price prediction. The best long-term & short-term REPLIGEN share price prognosis for 2021, 2022, 2023, 2024, 2025, 2026 with daily Repligen Corp. 's earnings in 2021 is $59,926,000.. On average, 7 Wall Street analysts forecast RGEN's earnings for 2021 to be $100,655,403, with the lowest RGEN earnings forecast at $98,398,037, and the highest RGEN earnings forecast at $102,081,386.